相似文献
1
Lifetime risk from polyurethane covered breast implants.
Environ Health Perspect. 1998 Nov;106(11):A526-7. doi: 10.1289/ehp.106-1533489.
2
Safety of polyurethane-covered breast implants. Expert Panel on the Safety of Polyurethane-covered Breast Implants.
CMAJ. 1991 Nov 1;145(9):1125-32.
3
Late hematoma after breast implantation.
Aesthetic Plast Surg. 2004 Mar-Apr;28(2):80-2. doi: 10.1007/s00266-004-3120-8. Epub 2004 Jun 1.
4
Polyurethane-coated silicone gel breast implants used for 18 years.
Aesthetic Plast Surg. 2007 Jul-Aug;31(4):330-6. doi: 10.1007/s00266-006-0207-4.
5
Polyurethane foam-covered breast implants: a justified choice?
Eur Rev Med Pharmacol Sci. 2015;19(9):1600-6.
6
A ten-year experience using polyurethane-covered breast implants.
Aesthetic Plast Surg. 1999 May-Jun;23(3):189-96. doi: 10.1007/s002669900267.
7
The In Vivo Pericapsular Tissue Response to Modern Polyurethane Breast Implants.
Aesthetic Plast Surg. 2015 Oct;39(5):713-23. doi: 10.1007/s00266-015-0550-4. Epub 2015 Aug 25.
8
Polyurethane Implants in 2-Stage Breast Reconstruction: 9-Year Clinical Experience.
Aesthet Surg J. 2017 Feb;37(2):171-176. doi: 10.1093/asj/sjw183. Epub 2016 Dec 9.
9
A simple method to inset and position polyurethane-covered breast implants.
Aesthetic Plast Surg. 2014 Apr;38(2):365-8. doi: 10.1007/s00266-014-0285-7. Epub 2014 Mar 8.
10
The Modern Polyurethane-Coated Implant in Breast Augmentation: Long-Term Clinical Experience.
Aesthet Surg J. 2016 Nov;36(10):1124-1129. doi: 10.1093/asj/sjw171. Epub 2016 Sep 27.
本文引用的文献
1
OBSERVATIONS ON SUBCUTANEOUSLY IMPLANTED POLYETHERURETHANE SPONGE IN MICE.
Surg Gynecol Obstet. 1963 Oct;117:454-8.
2
An investigation of polyurethane foam in experimental animals.
Can J Surg. 1963 Jul;6:371-82.
3
Research in plastic implants. Their use in augmentation for amastia or hypomastia.
J Int Coll Surg. 1961 May;35:630-43.
4
Augmentation mammaplasty--a further review of 20 years using the polyurethane-covered prosthesis.
J Long Term Eff Med Implants. 1992;1(3):269-79.
5
A physiologically based pharmacokinetic model for 2,4-toluenediamine leached from polyurethane foam-covered breast implants.
Environ Health Perspect. 1998 Jul;106(7):393-400. doi: 10.1289/ehp.98106393.
6
Measurement of 2,4-toluenediamine in urine and serum samples from women with Même or Replicon breast implants.
Plast Reconstr Surg. 1997 Oct;100(5):1291-8. doi: 10.1097/00006534-199710000-00035.
7
Mortality of workers exposed to toluene diisocyanate in the polyurethane foam industry.
Occup Environ Med. 1996 Oct;53(10):703-7. doi: 10.1136/oem.53.10.703.
8
9
Cancer incidence and mortality in the Swedish polyurethane foam manufacturing industry.
Br J Ind Med. 1993 Jun;50(6):537-43. doi: 10.1136/oem.50.6.537.
10
Mortality and cancer morbidity of production workers in the United Kingdom flexible polyurethane foam industry.
Br J Ind Med. 1993 Jun;50(6):528-36. doi: 10.1136/oem.50.6.528.
Zotero 插件